Global Autologous Matrix-induced Chondrogenesis Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 140475
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 120
  • list Pharmaceuticals and Healthcare

utologous matrix-induced chondrogenesis (AMIC) is a 1-step cartilage restoration technique that combines microfracture with the use of an exogenous scaffold.

Scope of the Report:

This report focuses on the Autologous Matrix-induced Chondrogenesis in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The functional principle of microfracturing is based on the release of multipotent mesenchymal progenitor cells, cytokines and growth factors from the subchondral bone. 

The worldwide market for Autologous Matrix-induced Chondrogenesis is expected to grow at a CAGR of roughly 8.0% over the next five years, will reach 160 million US$ in 2023, from 100 million US$ in 2017, according to a new study.

Market Segment by Manufacturers, this report covers

JRI Orthopaedics Ltd

BioTissue

Anika Therapeutics

B. Braun Melsungen

Arthro-Kinetics

Geistlich Pharma

CartiHeal

Matricel

Smith & Nephew

Zimmer Biomet Holdings

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Hyaluronic Acid

Collagen

Polyethylene Glycol (PEG)

Poly Lactic-Co-Glycolic Acid (PGLA)

Market Segment by Applications, can be divided into

Knees Joint

Other

There are 15 Chapters to deeply display the global Autologous Matrix-induced Chondrogenesis market.

Chapter 1, to describe Autologous Matrix-induced Chondrogenesis Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Autologous Matrix-induced Chondrogenesis, with sales, revenue, and price of Autologous Matrix-induced Chondrogenesis, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Autologous Matrix-induced Chondrogenesis, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Autologous Matrix-induced Chondrogenesis market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Autologous Matrix-induced Chondrogenesis sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Autologous Matrix-induced Chondrogenesis Introduction

1.2 Market Analysis by Type

1.2.1 Hyaluronic Acid

1.2.2 Collagen

1.2.3 Polyethylene Glycol (PEG)

1.2.4 Poly Lactic-Co-Glycolic Acid (PGLA)

1.3 Market Analysis by Applications

1.3.1 Knees Joint

1.3.2 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 JRI Orthopaedics Ltd

2.1.1 Business Overview

2.1.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 JRI Orthopaedics Ltd Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 BioTissue

2.2.1 Business Overview

2.2.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 BioTissue Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Anika Therapeutics

2.3.1 Business Overview

2.3.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Anika Therapeutics Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 B. Braun Melsungen

2.4.1 Business Overview

2.4.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 B. Braun Melsungen Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Arthro-Kinetics

2.5.1 Business Overview

2.5.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Arthro-Kinetics Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Geistlich Pharma

2.6.1 Business Overview

2.6.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Geistlich Pharma Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 CartiHeal

2.7.1 Business Overview

2.7.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 CartiHeal Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Matricel

2.8.1 Business Overview

2.8.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Matricel Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Smith & Nephew

2.9.1 Business Overview

2.9.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Smith & Nephew Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Zimmer Biomet Holdings

2.10.1 Business Overview

2.10.2 Autologous Matrix-induced Chondrogenesis Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Zimmer Biomet Holdings Autologous Matrix-induced Chondrogenesis Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Autologous Matrix-induced Chondrogenesis Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Autologous Matrix-induced Chondrogenesis Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Autologous Matrix-induced Chondrogenesis Manufacturer Market Share in 2017

3.3.2 Top 6 Autologous Matrix-induced Chondrogenesis Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Autologous Matrix-induced Chondrogenesis Market Analysis by Regions

4.1 Global Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Regions

4.1.1 Global Autologous Matrix-induced Chondrogenesis Sales and Market Share by Regions (2013-2018)

4.1.2 Global Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Regions (2013-2018)

4.2 North America Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

4.3 Europe Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

4.5 South America Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

5 North America Autologous Matrix-induced Chondrogenesis by Countries

5.1 North America Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries

5.1.1 North America Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)

5.1.2 North America Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)

5.2 United States Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

5.3 Canada Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

5.4 Mexico Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

6 Europe Autologous Matrix-induced Chondrogenesis by Countries

6.1 Europe Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries

6.1.1 Europe Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)

6.2 Germany Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

6.3 UK Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

6.4 France Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

6.5 Russia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

6.6 Italy Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

7 Asia-Pacific Autologous Matrix-induced Chondrogenesis by Countries

7.1 Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)

7.2 China Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

7.3 Japan Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

7.4 Korea Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

7.5 India Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

8 South America Autologous Matrix-induced Chondrogenesis by Countries

8.1 South America Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries

8.1.1 South America Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)

8.1.2 South America Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

8.3 Argentina Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

8.4 Colombia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

9 Middle East and Africa Autologous Matrix-induced Chondrogenesis by Countries

9.1 Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Autologous Matrix-induced Chondrogenesis Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

9.3 UAE Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

9.4 Egypt Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

9.5 Nigeria Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

9.6 South Africa Autologous Matrix-induced Chondrogenesis Sales and Growth Rate (2013-2018)

10 Global Autologous Matrix-induced Chondrogenesis Market Segment by Type

10.1 Global Autologous Matrix-induced Chondrogenesis Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Autologous Matrix-induced Chondrogenesis Sales and Market Share by Type (2013-2018)

10.1.2 Global Autologous Matrix-induced Chondrogenesis Revenue and Market Share by Type (2013-2018)

10.2 Hyaluronic Acid Sales Growth and Price

10.2.1 Global Hyaluronic Acid Sales Growth (2013-2018)

10.2.2 Global Hyaluronic Acid Price (2013-2018)

10.3 Collagen Sales Growth and Price

10.3.1 Global Collagen Sales Growth (2013-2018)

10.3.2 Global Collagen Price (2013-2018)

10.4 Polyethylene Glycol (PEG) Sales Growth and Price

10.4.1 Global Polyethylene Glycol (PEG) Sales Growth (2013-2018)

10.4.2 Global Polyethylene Glycol (PEG) Price (2013-2018)

10.5 Poly Lactic-Co-Glycolic Acid (PGLA) Sales Growth and Price

10.5.1 Global Poly Lactic-Co-Glycolic Acid (PGLA) Sales Growth (2013-2018)

10.5.2 Global Poly Lactic-Co-Glycolic Acid (PGLA) Price (2013-2018)

11 Global Autologous Matrix-induced Chondrogenesis Market Segment by Application

11.1 Global Autologous Matrix-induced Chondrogenesis Sales Market Share by Application (2013-2018)

11.2 Knees Joint Sales Growth (2013-2018)

11.3 Other Sales Growth (2013-2018)

12 Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)

12.1 Global Autologous Matrix-induced Chondrogenesis Sales, Revenue and Growth Rate (2018-2023)

12.2 Autologous Matrix-induced Chondrogenesis Market Forecast by Regions (2018-2023)

12.2.1 North America Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)

12.2.2 Europe Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)

12.2.3 Asia-Pacific Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)

12.2.4 South America Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)

12.2.5 Middle East and Africa Autologous Matrix-induced Chondrogenesis Market Forecast (2018-2023)

12.3 Autologous Matrix-induced Chondrogenesis Market Forecast by Type (2018-2023)

12.3.1 Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Type (2018-2023)

12.3.2 Global Autologous Matrix-induced Chondrogenesis Market Share Forecast by Type (2018-2023)

12.4 Autologous Matrix-induced Chondrogenesis Market Forecast by Application (2018-2023)

12.4.1 Global Autologous Matrix-induced Chondrogenesis Sales Forecast by Application (2018-2023)

12.4.2 Global Autologous Matrix-induced Chondrogenesis Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Autologous Matrix-induced Chondrogenesis Picture

Table Product Specifications of Autologous Matrix-induced Chondrogenesis

Figure Global Sales Market Share of Autolog

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery